Free Trial

Bone Biologics (BBLG) Competitors

Bone Biologics logo
$4.74 -0.55 (-10.32%)
Closing price 03:59 PM Eastern
Extended Trading
$5.02 +0.28 (+6.02%)
As of 05:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BBLG vs. INBS, PAVM, SSKN, LUCY, CODX, NURO, POAI, STRR, TNON, and IINN

Should you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Intelligent Bio Solutions (INBS), PAVmed (PAVM), STRATA Skin Sciences (SSKN), Innovative Eyewear (LUCY), Co-Diagnostics (CODX), NeuroMetrix (NURO), Predictive Oncology (POAI), Star Equity (STRR), Tenon Medical (TNON), and Inspira Technologies Oxy B.H.N. (IINN). These companies are all part of the "medical equipment" industry.

Bone Biologics vs. Its Competitors

Intelligent Bio Solutions (NASDAQ:INBS) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings, community ranking, profitability and media sentiment.

Intelligent Bio Solutions has a beta of 4.58, suggesting that its stock price is 358% more volatile than the S&P 500. Comparatively, Bone Biologics has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.

Bone Biologics has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -323.79%. Bone Biologics' return on equity of -124.71% beat Intelligent Bio Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Intelligent Bio Solutions-323.79% -146.03% -83.62%
Bone Biologics N/A -124.71%-111.64%

Intelligent Bio Solutions and Bone Biologics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Intelligent Bio SolutionsOutperform Votes
No Votes
Underperform Votes
1
100.00%
Bone BiologicsN/AN/A

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 34.3% of Bone Biologics shares are held by institutional investors. 1.5% of Intelligent Bio Solutions shares are held by insiders. Comparatively, 6.1% of Bone Biologics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Bone Biologics has lower revenue, but higher earnings than Intelligent Bio Solutions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intelligent Bio Solutions$2.94M4.49-$10.16MN/AN/A
Bone BiologicsN/AN/A-$8.95MN/AN/A

In the previous week, Intelligent Bio Solutions and Intelligent Bio Solutions both had 5 articles in the media. Intelligent Bio Solutions' average media sentiment score of 1.01 beat Bone Biologics' score of 0.32 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intelligent Bio Solutions
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bone Biologics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Bone Biologics beats Intelligent Bio Solutions on 5 of the 9 factors compared between the two stocks.

Get Bone Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBLG vs. The Competition

MetricBone BiologicsSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$2.58M$9.14B$5.58B$8.50B
Dividend YieldN/A1.26%5.28%4.17%
P/E RatioN/A20.6127.1919.64
Price / SalesN/A45.06408.78152.17
Price / CashN/A19.6738.3234.64
Price / Book0.645.086.974.60
Net Income-$8.95M$284.66M$3.23B$248.06M
7 Day Performance-1.51%-3.73%-0.88%-1.02%
1 Month Performance1.83%-7.34%7.81%3.51%
1 Year Performance-49.41%-22.76%31.53%12.68%

Bone Biologics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBLG
Bone Biologics
1.358 of 5 stars
$4.74
-10.3%
N/A-39.7%$2.58MN/A0.002Stock Split
Short Interest ↓
INBS
Intelligent Bio Solutions
0.476 of 5 stars
$1.55
+8.4%
N/A-15.2%$10.71M$2.94M0.0010Positive News
Gap Down
PAVM
PAVmed
3.781 of 5 stars
$0.63
+2.7%
$19.50
+3,014.0%
-35.4%$10.70M$1.99M-0.1490
SSKN
STRATA Skin Sciences
2.8424 of 5 stars
$2.40
-3.2%
$6.00
+150.0%
-26.2%$10.01M$33.62M-0.90120Short Interest ↑
Gap Down
LUCY
Innovative Eyewear
1.2074 of 5 stars
$3.06
-1.9%
N/A-73.6%$9.47M$1.71M-0.329Short Interest ↓
CODX
Co-Diagnostics
4.1727 of 5 stars
$0.28
+7.1%
$5.50
+1,865.7%
-78.8%$9.39M$3.71M-0.20100Short Interest ↑
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+17.9%$9.37M$3.03M-0.9920High Trading Volume
POAI
Predictive Oncology
1.9646 of 5 stars
$0.94
-0.7%
$3.00
+218.1%
-26.7%$8.42M$1.73M-0.3130News Coverage
Short Interest ↑
Gap Down
STRR
Star Equity
2.8275 of 5 stars
$2.59
-3.0%
$5.00
+93.1%
-51.7%$8.31M$57.17M-1.01460Short Interest ↑
TNON
Tenon Medical
2.8124 of 5 stars
$1.07
-0.9%
$4.67
+336.1%
+46.9%$8.12M$3.28M-0.048News Coverage
Short Interest ↓
IINN
Inspira Technologies Oxy B.H.N.
2.2431 of 5 stars
$0.64
+2.5%
$2.00
+213.1%
-60.9%$8.06MN/A0.0020Short Interest ↑

Related Companies and Tools


This page (NASDAQ:BBLG) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners